Fresh Tracks Therapeutics Stock Net Income
| FRTXDelisted Stock | USD 0.78 0.09 10.34% |
Fresh Tracks Therapeutics fundamentals help investors to digest information that contributes to Fresh Tracks' financial success or failures. It also enables traders to predict the movement of Fresh Pink Sheet. The fundamental analysis module provides a way to measure Fresh Tracks' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fresh Tracks pink sheet.
Fresh |
Fresh Tracks Therapeutics Company Net Income Analysis
Fresh Tracks' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Fresh Tracks Net Income | (21.1 M) |
Most of Fresh Tracks' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresh Tracks Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Fresh Tracks Therapeutics reported net income of (21.1 Million). This is 106.18% lower than that of the Biotechnology sector and 130.13% lower than that of the Health Care industry. The net income for all United States stocks is 103.7% higher than that of the company.
Fresh Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fresh Tracks' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Fresh Tracks could also be used in its relative valuation, which is a method of valuing Fresh Tracks by comparing valuation metrics of similar companies.Fresh Tracks is currently under evaluation in net income category among its peers.
Fresh Fundamentals
| Return On Equity | -0.81 | ||||
| Return On Asset | -0.42 | ||||
| Profit Margin | (0.89) % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | (4.04 M) | ||||
| Shares Outstanding | 5.97 M | ||||
| Shares Owned By Insiders | 11.62 % | ||||
| Shares Owned By Institutions | 8.96 % | ||||
| Number Of Shares Shorted | 50.18 K | ||||
| Price To Book | 0.45 X | ||||
| Price To Sales | 0.48 X | ||||
| Revenue | 6.94 M | ||||
| Gross Profit | (27.83 M) | ||||
| EBITDA | (21.09 M) | ||||
| Net Income | (21.1 M) | ||||
| Cash And Equivalents | 14.48 M | ||||
| Cash Per Share | 5.04 X | ||||
| Total Debt | 49 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 6.36 X | ||||
| Book Value Per Share | 1.85 X | ||||
| Cash Flow From Operations | (19.34 M) | ||||
| Short Ratio | 0.69 X | ||||
| Earnings Per Share | (2.32) X | ||||
| Target Price | 4.5 | ||||
| Number Of Employees | 13 | ||||
| Beta | 0.47 | ||||
| Market Capitalization | 4.84 M | ||||
| Total Asset | 10.27 M | ||||
| Retained Earnings | (166.47 M) | ||||
| Working Capital | 7.01 M | ||||
| Z Score | 31.28 | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 10.27 M |
About Fresh Tracks Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresh Tracks Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresh Tracks using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresh Tracks Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Fresh Pink Sheet
If you are still planning to invest in Fresh Tracks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fresh Tracks' history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |